关注
Kenneth B. Yeh
Kenneth B. Yeh
MRIGlobal
在 mriglobal.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Biosurveillance in Central Asia: Successes and challenges of tick-borne disease research in Kazakhstan and Kyrgyzstan
J Hay, KB Yeh, D Dasgupta, Z Shapieva, G Omasheva, P Deryabin, ...
Frontiers in Public Health 4, 4, 2016
322016
Significance of high-containment biological laboratories performing work during the COVID-19 pandemic: Biosafety level-3 and-4 labs
KB Yeh, K Tabynov, FK Parekh, I Mombo, K Parker, K Tabynov, ...
Frontiers in bioengineering and biotechnology 9, 720315, 2021
302021
National laboratory planning: developing sustainable biocontainment laboratories in limited resource areas
KB Yeh, M Adams, PD Stamper, D Dasgupta, R Hewson, CD Buck, ...
Health security 14 (5), 323-330, 2016
192016
Examining the utility and readiness of mobile and field transportable laboratories for biodefence and global health security-related purposes
A Parsons, P Matero, M Adams, K Yeh
Global Security: Health, Science and Policy 3 (1), 1-13, 2018
152018
Assessing Climate Change Impact on Ecosystems and Infectious Disease: Important Roles for Genomic Sequencing and a One Health Perspective.
RWJF Kenneth B. Yeh 1,*, Jeanne M. Fair 2, Woutrina Smith 3, Teresa ...
Tropical Medicine and Infectious Disease 5 (90), 2020
132020
Molecular detection of biological agents in the field: Then and now
KB Yeh, H Wood, M Scullion, JA Russell, K Parker, BT Gnade, AR Jones, ...
Msphere 4 (6), 10.1128/msphere. 00695-19, 2019
122019
The convergence of high-consequence livestock and human pathogen research and development: a paradox of zoonotic disease
JM Michelotti, KB Yeh, TR Beckham, MM Colby, D Dasgupta, KA Zuelke, ...
Tropical Medicine and Infectious Disease 3 (2), 55, 2018
122018
International Rickettsia Disease surveillance: an example of cooperative research to increase laboratory capability and capacity for risk assessment of rickettsial outbreaks …
J Jiang, CM Farris, KB Yeh, AL Richards
Frontiers in Medicine 8, 622015, 2021
102021
Infectious disease risks and vulnerabilities in the aftermath of an environmental disaster in Minas Gerais, Brazil
FK Parekh, KB Yeh, G Olinger, FA Ribeiro
Vector-Borne and Zoonotic Diseases 20 (5), 387-389, 2020
102020
Applying a Capability Maturity Model (CMM) to evaluate global health security-related research programmes in under-resourced areas
KB Yeh, ML Adams, ES Marshall, D Dasgupta, A Zhunushov, AL Richards, ...
Global Security: Health, Science and Policy 2 (1), 1-9, 2017
92017
Global health security threats and related risks in Latin America
KB Yeh, FK Parekh, B Borgert, GG Olinger, JM Fair
Global Security: Health, Science and Policy 6 (1), 18-25, 2021
82021
A case history in cooperative biological research: compendium of studies and program analyses in Kazakhstan
KB Yeh, FK Parekh, L Musralina, A Sansyzbai, K Tabynov, Z Shapieva, ...
Tropical Medicine and Infectious Disease 4 (4), 136, 2019
72019
Promoting scientific transparency to facilitate the safe and open international exchange of biological materials and electronic data
KB Yeh, C Monagin, J Fletcher
Tropical Medicine and Infectious Disease 2 (4), 57, 2017
72017
Climate change and infectious disease: A prologue on multidisciplinary cooperation and predictive analytics
KB Yeh, FK Parekh, I Mombo, J Leimer, R Hewson, G Olinger, JM Fair, ...
Frontiers in Public Health 11, 1018293, 2023
62023
Operationalizing cooperative research for infectious disease surveillance: lessons learned and ways forward
KB Yeh, FK Parekh, K Tabynov, K Tabynov, R Hewson, JM Fair, ...
Frontiers in Public Health 9, 659695, 2021
62021
Achieving health security and threat reduction through sharing sequence data
K Yeh, J Fair, H Cui, C Newman, G Braunstein, G Chanturia, S Vora, ...
Tropical Medicine and Infectious Disease 4 (2), 78, 2019
52019
Aerosol test chambers: current state and practice during the COVID-19 pandemic
KB Yeh, B Setser
Frontiers in bioengineering and biotechnology 10, 863954, 2022
42022
End-user perspectives on using quantitative real-time PCR and genomic sequencing in the field
K Parker, J Forman, G Bonheyo, B Knight, R Bartholomew, R Ozanich, ...
Tropical Medicine and Infectious Disease 7 (1), 6, 2022
42022
Biotechnology and biodefense enterprise: an industry perspective on defence acquisition
KB Yeh, E Du, G Olinger, D Boston
Global Security: Health, Science and Policy 7 (1), 37-43, 2022
32022
First movers in molecular detection: case comparison on harnessing research and development, industry, and entrepreneurship
KB Yeh, M Scullion, JM Michelotti, G Olinger
Frontiers in Medicine 8, 639440, 2021
32021
系统目前无法执行此操作,请稍后再试。
文章 1–20